Vitamin D resistance

American Journal of Medicine

Volumn 106, Issue 3, 1999, Pages 355-370

  Malloy, Peter J ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; RETINOIC ACID RECEPTOR; STEROID RECEPTOR; THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN D; VITAMIN D RECEPTOR;

DNA BINDING; GENE DELETION; GENE EXPRESSION REGULATION; GENETIC DISORDER; HUMAN; HYPOCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIGAND BINDING; MISSENSE MUTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RICKETS; VITAMIN D RESISTANT RICKETS;

EID: 0033105749     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00419-7     Document Type: Article

References (107)

1. Feldman D., Glorieux F.H., Pike J.W. Vitamin D. 1997;Academic Press, San Diego.
2. Mangelsdorf D.J., Thummel C., Beato M., et al. The nuclear receptor superfamily the second decade . Cell. 83:1995;835-839.
3. Feldman D., Malloy P.J., Gross C. Vitamin D: metabolism and action. Marcus R., Feldman D., Kelsey J. Osteoporosis. 1996;205-235 Academic Press, San Diego.
4. Bikle D.D. Clinical counterpoint Vitamin D: new actions, new analogs, new therapeutic potential . Endocrine Rev. 13:1992;765-784.
5. Walters M.R. Newly identified actions of the vitamin D endocrine system. Endocrine Rev. 13:1992;719-764.
6. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid Science. 206:1979;1188-1190.
7. Colston K., Hirst M., Feldman D. Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology. 107:1980;1916-1922.
8. 3 receptor in target cells. Endocrinology. 122:1988;1224-1230.
9. Berger U., Wilson P., McClelland R.A., et al. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 67:1988;607-613.
10. 3 on primary cultures of human prostatic cells. Cancer Res. 54:1994;805-810.
11. 3 receptors structure and function in transcription . Ann Rev Nutr. 11:1991;189-216.
12. Haussler M.R., Whitfield G.K., Haussler C.A., et al. The nuclear vitamin D receptor biological and molecular regulatory properties revealed . J Bone Min Res. 13:1998;325-349.
13. MacDonald P.N., Dowd D.R., Haussler M.R. New insight into the structure and functions of the vitamin D receptor. Semin Nephrol. 14:1994;101-118.
14. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
15. 3. Proc Natl Acad Sci USA. 89:1992;8097-8101.
16. McDonnell D.P., Mangelsdorf D.J., Pike J.W., Haussler M.R., O'Malley B.W. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science. 235:1987;1214-1217.
17. Baker A.R., McDonnell D.P., Hughes M., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA. 85:1988;3294-3298.
18. Labuda M., Fujiwara T.M., Ross M.V., et al. Two hereditary defects related to vitamin D metabolism map to the same region of human chromosome 12q13-14. J Bone Miner Res. 7:1992;1447-1453.
19. Miyamoto K., Kesterson R.A., Yamamoto H., et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 11:1997;1165-1179.
20. Saijo T., Ito M., Takeda E., et al. A unique mutation in the vitamin D receptor gene in three Japanese patients with vitamin D-dependent rickets type II utility of single-strand conformation polymorphism analysis for heterozygous carrier detection . Am J Hum Genet. 49:1991;668-673.
21. Malloy P.J., Pike J.W., Feldman D. Hereditary 1,25-dihydroxyvitamin D resistant rickets. Feldman D., Glorieux F., Pike J.W. Vitamin D. 1997;756-788 Academic Press, San Diego.
22. Gross C., Eccleshall T.R., Malloy P.J., Villa M.L., Marcus R., Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res. 11:1996;1850-1855.
23. Harris S.S., Eccleshall T.R., Gross C., Dawson-Hughes B., Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res. 12:1997;1043-1048.
24. Arai H., Miyamoto K.-I., Taketani Y., et al. A vitamin D receptor gene polymorphism in the translation initiation codon Effect on protein activity and relation to bone mineral density in Japanese women . J Bone Miner Res. 12:1997;915-921.
25. Eccleshall T.R., Garnero P., Gross C., Delmas P.D., Feldman D. Lack of correlation between the start codon polymorphism of the vitamin D receptor and bone mineral density in premenopausal French women. J Bone Miner Res. 13:1998;31-35.
26. 3 receptor regulate osteocalcin gene expression. Mol Endocrinol. 3:1989;635-644.
27. Zilliacus J., Wright A.P., Carlstedt-Duke J., Gustafsson J.A. Structural determinants of DNA-binding specificity by steroid receptors. Mol Endocrinol. 9:1995;389-400.
28. Hsieh J.C., Jurutka P.W., Selznick S.H., et al. The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation. Biochem Biophys Res Commun. 215:1995;1-7.
29. 3. J Nutr. 125:1995;1690S-1694S.
30. Freedman L.P., Lemon B.D. Structural and functional determinants of DNA binding and dimerization by the vitamin D receptor. Feldman D., Glorieux F.H., Pike J.W. Vitamin D. 1997;127-148 Academic Press, San Diego.
31. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697.
32. Renaud J.P., Rochel N., Ruff M., et al. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid Nature. 378:1995;681-689.
33. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature. 375:1995;377-382.
34. Whitfield G.K., Hsieh J.C., Nakajima S., et al. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation. Mol Endocrinol. 9:1995;1166-1179.
35. Jin C.H., Kerner S.A., Hong M.H., Pike J.W. Transcriptional activation and dimerization functions in the human vitamin D receptor. Mol Endocrinol. 10:1996;945-957.
36. Brooks M.H., Bell N.H., Love L., et al. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med. 298:1978;996-999.
37. Marx S.J., Spiegel A.M., Brown E.M., et al. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 47:1978;1303-1310.
38. 3 1alpha-hydroxylase and vitamin D synthesis. Science. 277:1997;1827-1830.
39. 3 1(alpha)-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med. 338:1998;653-661.
40. Balsan S., Garabedian M., Lieberherr M., Gueris J., Ulmann A. Serum 1,25-dihydroxyvitamin D concentrations in two different types of pseudo-deficiency rickets. Norman A.W., Bouillon R., Thomasset M. Vitamin D Basic Research and Its Clinical Application. Fourth Workshop on Vitamin D . 1979;1143-1149 Walter de Gruyter, New York.
41. Rosen J.F., Fleischman A.R., Finberg L., Hamstra A., DeLuca H.F. Rickets with alopecia an inborn error of vitamin D metabolism . J Pediatr. 94:1979;729-735.
42. Zerwekh J.E., Glass K., Jowsey J., Pak C.Y. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 49:1979;171-175.
43. Fujita T., Nomura M., Okajima S., Furuya H. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. J Clin Endocrinol Metab. 50:1980;927-931.
44. Liberman U.A., Samuel R., Halabe A., et al. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet. 1:1980;504-506.
45. 3 . J Pediatr. 96:1980;701-703.
46. Tsuchiya Y., Matsuo N., Cho H., et al. An unusual form of vitamin D-dependent rickets in a child alopecia and marked end-organ hyposensitivity to biologically active vitamin D . J Clin Endocrinol Metab. 51:1980;685-690.
47. Beer S., Tieder M., Kohelet D., et al. Vitamin D resistant rickets with alopecia A form of end organ resistance to 1,25-dihydroxyvitamin D . Clin Endocrinol. 14:1981;395-402.
48. Eil C., Liberman U.A., Rosen J.F., Marx S.J. A cellular defect in hereditary vitamin-D-dependent rickets type II defective nuclear uptake of 1,25-dihydroxyvitamin D in cultured skin fibroblasts . N Engl J Med. 304:1981;1588-1591.
49. Kudoh T., Kumagai T., Uetsuji N., et al. Vitamin D dependent rickets decreased sensitivity to 1,25-dihydroxyvitamin D . Eur J Pediatr. 137:1981;307-311.
50. 3 . J Clin Endocrinol Metab. 55:1982;1020-1022.
51. Balsan S., Garabedian M., Liberman U.A., et al. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D two different clinical courses with two different cellular defects . J Clin Endocrinol Metab. 57:1983;803-811.
52. 3 . J Clin Endocrinol Metab. 56:1983;824-830.
53. 3. J Clin Invest. 72:1983;1190-1199.
54. 3 association with heterogeneous defects in cultured skin fibroblasts . J Clin Invest. 71:1983;192-200.
55. Liberman U.A., Eil C., Holst P., Rosen J.F., Marx S.J. Hereditary resistance to 1,25-dihydroxyvitamin D defective function of receptors for 1,25-dihydroxyvitamin D in cells cultured from bone . J Clin Endocrinol Metab. 57:1983;958-962.
56. 3 in cultured dermal fibroblasts from patients with X-linked hypophosphatemia. J Clin Endocrinol Metab. 59:1984;556-560.
57. Chen T.L., Hirst M.A., Cone C.M., Hochberg Z., Tietze H.U., Feldman D. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia analysis of receptors and bioresponse in cultured fibroblasts from patients and parents . J Clin Endocrinol Metab. 59:1984;383-388.
58. Hochberg Z., Benderli A., Levy J., et al. 1,25-Dihydroxyvitamin D resistance, rickets, and alopecia. Am J Med. 77:1984;805-811.
59. 3 in cultured skin fibroblasts . J Clin Invest. 75:1985;954-960.
60. Hirst M.A., Hochman H.I., Feldman D. Vitamin D resistance and alopecia a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid . J Clin Endocrinol Metab. 60:1985;490-495.
61. Hochberg Z., Gilhar A., Haim S., Friedman-Birnbaum R., Levy J., Benderly A. Calcitriol-resistant rickets with alopecia. Arch Dermatol. 121:1985;646-647.
62. 3 receptors in peripheral mononuclear cells of patients with end-organ resistance to 1,25-dihydroxyvitamin D. J Clin Invest. 76:1985;2012-2015.
63. Castells S., Greig F., Fusi M.A., et al. Severely deficient binding of 1,25-dihydroxyvitamin D to its receptors in a patient responsive to high doses of this hormone. J Clin Endocrinol Metab. 63:1986;252-256.
64. 3 in a patient without alopecia . Eur J Pediatr. 145:1986;389-395.
65. Liberman U.A., Eil C., Marx S.J. Receptor-positive hereditary resistance to 1,25-dihydroxyvitamin D chromatography of receptor complexes on deoxyribonucleic acid-cellulose shows two classes of mutation . J Clin Endocrinol Metab. 62:1986;122-126.
66. Liberman U.A., Eil C., Marx S.J. Clinical features of hereditary resistance to 1,25-dihydroxyvitamin D (hereditary hypocalcemic vitamin D resistant rickets type II). Adv Exp Med Biol. 196:1986;391-406.
67. Sakati N., Woodhouse N.J.Y., Niles N., Harfi H., de Grange D.A., Marx S. Hereditary resistance to 1,25-dihydroxyvitamin D clinical and radiological improvement during high-dose oral calcium therapy . Hormone Res. 24:1986;280-287.
68. Takeda E., Kuroda Y., Saijo T., et al. Rapid diagnosis of vitamin D-dependent rickets type II by use of phytohemagglutinin-stimulated lymphocytes. Clin Chim Acta. 155:1986;245-250.
69. Laufer D., Benderly A., Hochberg Z. Dental pathology in calcitirol resistant rickets. J Oral Med. 42:1987;272-275.
70. 3. Br J Haematol. 67:1987;267-271.
71. Takeda E., Kuroda Y., Saijo T., et al. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia. Pediatrics. 80:1987;97-101.
72. Bliziotes M., Yergey A.L., Nanes M.S., et al. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D documentation and effective therapy with high dose intravenous calcium infusions . J Clin Endocrinol Metab. 66:1988;294-300.
73. 3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. J Clin Invest. 83:1989;2093-2101.
74. Malloy P.J., Hochberg Z., Pike J.W., Feldman D. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J Clin Endocrinol Metab. 68:1989;263-269.
75. Takeda E., Yokota I., Kawakami I., Hashimoto T., Kuroda Y., Arase S. Two siblings with vitamin-D-dependent rickets type II no recurrence of rickets for 14 years after cessation of therapy . Eur J Pediatr. 149:1989;54-57.
76. 3 receptor. Mol Cell Endocrinol. 70:1990;1-11.
77. 3 of cells from parents of patients with vitamin D-dependent rickets type II. J Clin Endocrinol Metab. 70:1990;1068-1074.
78. Yokota I., Takeda E., Ito M., Kobashi H., Saijo T., Kuroda Y. Clinical and biochemical findings in parents of children with vitamin D-dependent rickets Type II. J Inherit Metab Dis. 14:1991;231-240.
79. Simonin G., Chabrol B., Moulene E., et al. Vitamin D-resistant rickets type II apropos of 2 cases . Pediatrie. 47:1992;817-820.
80. Lin J.P., Uttley W.S. Intra-atrial calcium infusions, growth, and development in end organ resistance to vitamin D. Arch Dis Child. 69:1993;689-692.
81. Marx S.J., Bliziotes M.M., Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol. 25:1986;373-381.
82. 3. J Clin Invest. 92:1993;12-16.
83. Balsan S., Garabedian M., Larchet M., et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest. 77:1986;1661-1667.
84. Weisman Y., Bab I., Gazit D., Spirer Z., Jaffe M., Hochberg Z. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D. Am J Med. 83:1987;984-990.
85. Hochberg Z., Tiosano D., Even L. Calcium therapy for calcitriol-resistant rickets. J Pediatr. 121:1992;803-808.
86. 3 receptors in human skin biopsies. J Clin Endocrinol Metab. 51:1980;1463-1465.
87. 3 receptor. Proc Natl Acad Sci USA. 79:1982;7719-7723.
88. Hughes M.R., Malloy P.J., Kieback D.G., et al. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science. 242:1988;1702-1705.
89. 3-resistant rickets in three families. Proc Natl Acad Sci USA. 86:1989;9783-9787.
90. 3 resistant rickets in seven related families. J Clin Invest. 86:1990;2071-2079.
91. 3 in humans are transcriptionally inactive in vitro. J Biol Chem. 264:1989;20230-20234.
92. Malloy P.J., Hughes M.R., Pike J.W., Feldman D. Vitamin D receptor mutations and hereditary 1,25-dihydroxyvitamin D resistant rickets. Norman A.W., Bouillon R., Thomasset M. Vitamin D Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D . 1991;116-124 Walter de Gruyter, New York.
93. Wiese R.J., Goto H., Prahl J.M., et al. Vitamin D-dependency rickets type II truncated vitamin D receptor in three kindreds . Mol Cell Endocrinol. 90:1993;197-201.
94. Zhu W.J., Malloy P.J., Delvin E., Chabot G., Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor. J Bone Miner Res. 13:1998;259-264.
95. 3-resistant rickets. J Clin Endocrinol Metab. 82:1997;3892-3894.
96. Rut A.R., Hewison M., Rowe P., Hughes M., Grant D., O'Riordan J.L.H. A novel mutation in the steroid binding region of the vitamin D receptor (VDR) gene in hereditary vitamin D resistant rickets (HVDRR). Norman A.W., Bouillon R., Thomasset M. Vitamin D Gene Regulation, Structure-Function Analysis, and Clinical Application. Eighth Workshop on Vitamin D . 1991;94-95 Walter de Gruyter, New York.
97. Malloy P.J., Eccleshall T.R., Gross C., Van Maldergem L., Bouillon R., Feldman D. Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest. 99:1997;297-304.
98. Van Maldergem L., Bachy A., Feldman D., et al. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent müllerian ducts in a Turkish boy born to consanguineous parents. Am J Med Genet. 64:1996;506-513.
99. 3 point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner . Mol Endocrinol. 10:1996;1617-1631.
100. Cockerill F.J., Hawa N.S., Yousaf N., Hewison M., O'Riordan J.L., Farrow S.M. Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets. J Clin Endocrinol Metab. 82:1997;3156-3160.
101. Thompson E, Kristjansson K, Hughes M. Molecular scanning methods for mutation detection: application to the 1,25-dihydroxyvitamin D receptor. Eighth Workshop on Vitamin D, Paris, France, 1991.
102. Hawa N.S., Cockerill F.J., Vadher S., et al. Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping. Clin Endocrinol. 45:1996;85-92.
103. Hewison M., Rut A.R., Kristjansson K., et al. Tissue resistance to 1,25-dihydroxyvitamin D without a mutation of the vitamin D receptor gene. Clin Endocrinol. 39:1993;663-670.
104. Manolagas S.C., Yu X.P., Girasole G., Bellido T. Vitamin D and the hematolymphopoietic tissue a 1994 update . Semin Nephrol. 14:1994;129-143.
105. Underwood J.L., DeLuca H.F. Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol. 246:1984;493-498.
106. Weisman Y., Jaccard N., Legum C., et al. Prenatal diagnosis of vitamin D-dependent rickets, type II response to 1,25-dihydroxyvitamin D in amniotic fluid cells and fetal tissues . J Clin Endocrinol Metab. 71:1990;937-943.
107. 3 binding, 24-hydroxylase induction and RFLP analysis. Ninth Workshop on Vitamin D, Orlando, 1994.